Verzenio is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Abemaciclib.
Product ID | 0002-4815_268939ac-da7c-4fb5-ba8d-0d59aed8df3f |
NDC | 0002-4815 |
Product Type | Human Prescription Drug |
Proprietary Name | Verzenio |
Generic Name | Abemaciclib |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-09-28 |
Marketing Category | NDA / NDA |
Application Number | NDA208716 |
Labeler Name | Eli Lilly and Company |
Substance Name | ABEMACICLIB |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Kinase Inhibitors [MoA],Kinase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-10-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208716 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-06 |
Ingredient | Strength |
---|---|
ABEMACICLIB | 100 mg/1 |
SPL SET ID: | be4bc0de-0fdc-4d46-8d25-be43c79e6a06 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0002-4483 | Verzenio | abemaciclib |
0002-4815 | Verzenio | abemaciclib |
0002-5337 | Verzenio | abemaciclib |
0002-6216 | Verzenio | abemaciclib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VERZENIO 87712095 5746611 Live/Registered |
Eli Lilly and Company 2017-12-07 |
VERZENIO 87147864 5429204 Live/Registered |
Eli Lilly and Company 2016-08-23 |
VERZENIO 85864138 not registered Dead/Abandoned |
Eli Lilly and Company 2013-03-01 |